I specialise in the study of difficult-to-treat malignancies with unmet clinical needs, with a particular focus in the neuro-oncology setting
I have significant expertise in the development of advanced preclinical models of Glioblastoma (GBM), interrogation of tumour microenvironment contexts of vulnerability, development of novel pre-clinical radiomic pipelines and investigation of mechanisms of response to immunotherapy.
My research currently aims to develop a novel gene therapy approach for the treatment of brain tumour-related epilepsy using state-of-the-art preclinical GBM models and ex vivo electrophysiological techniques.
